ACC and SVS Begin 2021 with a United Vascular Registry
Existing registries have now combined into a single resource focused on improving care and outcomes of patients with vascular disease
WASHINGTON (February 4, 2021) — The American College of Cardiology and Society for Vascular Surgery have moved to a single vascular registry to harness the strengths of both organizations in improving care and outcomes of patients with vascular disease.
Effective January 1, 2021, the ACC NCDR Peripheral Vascular Intervention (PVI) registry is now operated by SVS, creating a co-branded VQI program that is a unique and comprehensive resource for measuring and improving the care provided to a growing population of patients with vascular diseases. The ACC’s PVI Registry will not enroll new hospitals for 2021, but will now be managed by SVS. The ACC data collection tool will remain open through April 15, 2021, to allow sites to complete data entry for Q4 2020 and receive a final 2020 outcomes report. Hospitals will be able to access their historical PVI Registry data through Dec. 31, 2021, allowing hospitals time to determine how they would like to store or transfer these past records and reports.
ACC NCDR participants who have not yet joined the SVS VQI, may contact the SVS VQI account team by emailing email@example.com, or by calling 603-298-6717, to begin enrollment.
The new registry collaboration provides greater opportunities to evaluate new and emerging technologies, pharmacologic therapies, and medical and lifestyle management. It also provide a rich source of data for academicians, the FDA and industry looking to answer scientific questions about patient characteristics and outcomes and the use and effectiveness of different treatments.
“The combined strengths of ACC and SVS provide a clear choice for clinicians, researchers, industry and the Food and Drug Administration when looking for data on the management of vascular diseases,” said Fred Masoudi, MD, MPH, FACC, ACC NCDR Oversight Committee chair and chief scientific advisor.
“This single registry combines the resources and expertise from both organizations. We have merged the best elements of both registries to create the premier vascular clinical registry,” said VQI Medical Director Jens Jorgensen, MD. “We look forward to working with the ACC and other medical society collaborators to enrich the VQI and improve the care of vascular patients.”
Originating as the CARE Registry in 2006 and expanding scope in 2014 to include lower extremity vascular catheter-based interventions, the ACC’s Peripheral Vascular Intervention (PVI) Registry assesses the prevalence, demographics, management and outcomes of patients undergoing percutaneous treatment for peripheral vascular disease. To date, the PVI Registry includes patient data from more than 200 institutions.
VQI began in 2010 as an expansion of the Vascular Study Group of New England, which originated in 2003. More than 750 centers participate in VQI, which has 14 procedural-based registries encompassing the treatment of arterial and venous disease as well as a disease-based registry collecting data on the medical management of aneurysms, carotid stenosis and lower extremity arterial occlusive disease.
The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit acc.org.
The Society for Vascular Surgery is the leading not-for-profit, professional medical society on establishing causes and treatments for vascular disease. SVS seeks to advance excellence and innovation in vascular health through education, advocacy, research and public awareness and is composed of specialty-trained vascular surgeons who are dedicated to providing comprehensive care for vascular disease.